What Researchers Did
Researchers evaluated the long-term outcomes of 45 patients with locally advanced laryngeal carcinoma treated with a unique hypofractionated radiation schedule and concomitant hyperbaric oxygen at 4 atmospheres of pressure.
What They Found
Complete clinical responses were observed in 39 (87%) of the 45 cases. The 10-year local control rate for all patients was 58%, increasing to 69% for complete responders. The overall 10-year survival rate for the population was 27%.
What This Means for Canadian Patients
This study suggests that a specific hypofractionated radiation regimen combined with hyperbaric oxygen could be an option for treating locally advanced laryngeal cancer. Patients should discuss all treatment options, including potential benefits and long-term side effects, with their oncology team.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in the United States and does not involve Canadian researchers or patients.
Study Limitations
Limitations include the small sample size of 45 patients, the single-center design, and the historical nature of the data from 1970-1982.